ANVS vs TLRY · $80.4M cap vs rev $915.5M
Annovis Bio Inc (ANVS) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ANVS revenue for 2026-06-30 was $0. Net income was -$32.4M. ANVS currently screens at market cap $80.4M.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
ANVS currently screens at market cap $80.4M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the ANVS and TLRY stock pages for the full models.
Not investment advice.